查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1807521

按产品类型、程序、技术、性别、类别、应用、最终用户和分销管道分類的美容医疗市场 - 2025-2030 年全球预测

Aesthetic Medicine Market by Product Type, Procedures, Technology, Gender, Category, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年美容医疗市场价值将达212.4亿美元，2025年成长至228.3亿美元，复合年增长率为7.75%，到2030年将达到332.6亿美元。

主要市场统计数据
基准年2024年 212.4亿美元
预计2025年 228.3亿美元
预计2030年 332.6亿美元
复合年增长率（%） 7.75%

探索美容医学的不断发展以及管理概述对指导行业决策的战略重要性

随着科技创新与消费者不断变化的期望不断融合，美容医疗市场正经历前所未有的变革。在全球对健康和自我护理的关注推动下，美容治疗正在超越传统的整容手术，转向各种安全、有效且恢復期短的微创手术。

分析重塑美容医学的突破性转变，这些转变由推动不断变化的消费者偏好和不断调整的监管环境的最尖端科技推动

一系列变革性变革正在再形成美容医学格局，重新定义治疗的构思、实施和体验方式。雷射系统的进步带来了前所未有的精准度，使医生能够精准瞄准组织并最大程度地减少附带损伤；而冷冻技术和聚焦超音波已成为非手术塑形的强效方法，减少了对侵入性手术的依赖。

2025年美国关税对供应链定价策略和市场准入的累积影响的全面评估

2025年美国关税的实施，正在对美容医疗的供应链和成本结构产生累积影响。这些关税最初是为了解决更广泛的贸易失衡问题而实施的，它既影响成品美容设备，也影响注射剂（例如皮肤填充剂和神经毒素）的基本原材料。因此，製造商面临着不断上升的投入成本，有必要在其采购和生产流程中实施策略成本管理。

美容医学的多方面市场细分趋势揭示了产品类型、程序、技术、性别、类别和应用的趋势

深入研究市场细分，有助于深入了解美容医学领域的消费行为和成长动力。按产品类型分析，由于能量技术的持续创新，先进的美容设备正在吸引大量投资；而随着消费者追求非侵入式护肤方案，乳霜和凝胶的需求保持稳定。同时，植入、注射和填充剂也不断发展，配方经过改进，生物相容性和使用寿命也提高。

区域分析突显了美洲、欧洲、中东和非洲以及亚太市场不同的成长轨迹和战略机会

美容医学的区域动态凸显了不同地区不同的成长轨迹和策略考量。在美洲，美国凭藉对先进技术的强劲投资和高消费能力，已稳固确立了其全球领导者的地位。南美市场则受到不断壮大的中产阶级和对美容的强烈文化接受度的推动，这为非侵入性治疗的普及创造了肥沃的土壤。

美容医学的创新伙伴关係和竞争格局：看看推动市场发展的主要企业

美容医学领域的领导者以其对持续创新、策略伙伴关係和地理扩张的承诺而闻名。领先的设备製造商正在大力投资研发，以改进其基于能量的平台并增强用户介面，从而透过差异化的性能和安全性确保竞争优势。同时，注射药物製造商正在透过优先考虑生物刺激特性和最大程度减少不利事件的下一代製剂来丰富其产品线。

策略建议，帮助产业领导者利用新兴趋势、优化营运并应对不断变化的法规环境

为了充分利用美容医学的动态变化，产业领导者应优先投资能够提升安全性和病患舒适度的下一代技术。与技术创新者建立合作关係，将有助于及早获得突破性治疗方法，并简化产品开发週期。此外，透过多元化采购和策略性库存管理来优化供应链弹性，可以减轻未来贸易政策变化的影响。

透明的调查方法，详细说明资料来源、分析方法、检验流程和品质保证通讯协定

本报告的调查方法融合了定性和定量分析，以确保提供可靠且稳健的洞察。主要资料收集包括与主要市场的关键意见领袖、医疗设备製造商、临床医生和监管专家进行结构化访谈。这些访谈提供了关于技术应用、市场挑战和策略重点的第一手观点。

影响美容医学未来的关键发现和策略要点的总结性综合

本执行摘要总结了阐明美容医学发展格局的关键发现。能量型和注射型平台的技术突破，加上不断变化的患者期​​望和不断调整的法律规范，正在重新定义医生可用的治疗方法。同时，2025年美国关税的实施凸显了敏捷供应链策略和自适应定价模式的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 人工智慧驱动的影像分析整合提供个人化的填充剂剂量和注射建议
  • 引入远距美容咨询，使用虚拟实境脸部映射来指导远端医疗计划
  • 新型肌肉选择性神经毒素获得监管部门核准，针对脸部小肌肉改善微皱纹
  • 增强皮肤屏障功能、减少光老化的多核苷酸和胜肽混合物的流行
  • 增加对 3D 生物列印脸部软骨的投资，用于法令纹增大和结构支撑
  • 使用植物来源透明质酸替代品的永续生物技术皮肤填充剂的出现
  • 用于非侵入式紧緻肌肤的家用轻护肤设备需求激增
  • 利用冷冻溶脂和高强度聚焦超音波拓展男性微创体型雕塑治疗
  • 以外泌体为基础的皮肤再生疗法在美容诊所的快速发展

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章：2025年美国关税的累积影响

第 8 章：按产品类型分類的美容医疗市场

  • 美容仪器
  • 乳霜和凝胶
  • 植入
  • 注射剂和填充剂

第九章 美容医疗市场（依流程）

  • 非侵入性手术
  • 外科手术

第 10 章：美容医疗市场（按技术）

  • 低温技术
  • 雷射底座
  • LED 底座
  • 超音波

第11章 美容医疗市场：性别

  • 女士
  • 男性

第 12 章：美容医疗市场（按类别）

  • 非专利的
  • 处方药

第 13 章：美容医疗市场（按应用）

  • 体型雕塑
    • 非手术体型雕塑
      • 冷冻溶脂
      • HIFU
    • 手术体型雕塑
      • 腹部手术
      • 抽脂手术
  • 脸部回春
    • 肉毒桿菌毒素
    • 皮肤填充剂
    • 埋线拉提
  • 疤痕治疗
  • 活肤
    • 化学换肤
    • 雷射治疗
    • 微晶换肤

第十四章 医疗美容市场（依最终用户）

  • 美容中心
  • 皮肤科诊所
  • 居家照护环境
  • 医院
  • 医疗水疗中心

第15章 美容医疗市场（依分销管道）

  • 医院药房
  • 网路药局
  • 零售药局

第16章：美洲美容医疗市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第十七章：欧洲、中东和非洲的医疗美容市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第十八章：亚太美容医疗市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十九章 竞争态势

  • 2024年市场占有率分析
  • FPNV定位矩阵2024
  • 竞争分析
    • AbbVie Inc.
    • Aerolase Corp
    • Apyx Medical Corporation
    • BIOTEC ITALIA SRL
    • BTL Group
    • Candela Corporation
    • Cutera, Inc.
    • Cynosure Inc.
    • El.En. Spa
    • EndyMed
    • Fotona doo
    • Galderma SA
    • Inmode Ltd
    • Ipsen Pharma
    • Jeisys Medical Co., Ltd.
    • Lumenis Be Ltd.
    • Lutronic Inc.
    • Merz Pharma GmbH & Co.KGaA
    • Quanta System SpA
    • Revance Therapeutics, Inc.
    • Sciton, Inc.
    • Sinclair Pharma Ltd.
    • Venus Concept
    • Bausch Health Companies Inc.
    • Cutis Medical Laser Clinics Pte Ltd

第20章 研究人工智慧

第21章 研究统计

第22章 研究联络人

第23章 研究报导

第24章 附录

Product Code: MRR-B9334AD6C212

The Aesthetic Medicine Market was valued at USD 21.24 billion in 2024 and is projected to grow to USD 22.83 billion in 2025, with a CAGR of 7.75%, reaching USD 33.26 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 21.24 billion
Estimated Year [2025] USD 22.83 billion
Forecast Year [2030] USD 33.26 billion
CAGR (%) 7.75%

Discover the evolving landscape of aesthetic medicine and the strategic importance of an executive overview that informs and guides industry decision-making

To begin with, the aesthetic medicine field has experienced an unprecedented transformation as technological innovation converges with evolving consumer expectations. Fueled by a global emphasis on wellness and self-care, aesthetic treatments have moved beyond traditional cosmetic surgery to include a diverse spectrum of minimally invasive procedures designed for safety, efficacy, and minimal downtime.

Moreover, the industry's rapid evolution is underpinned by sophisticated device development and a shift toward personalized therapeutic approaches. In parallel, demographic changes-such as aging populations in developed markets and rising disposable incomes in emerging economies-are amplifying demand for noninvasive rejuvenation solutions and comprehensive skin health regimens.

Consequently, stakeholders from device manufacturers to clinical practitioners require a concise executive overview to contextualize these emerging trends, policy impacts, and competitive dynamics. This summary distills critical insights on transformative technological breakthroughs, recent United States trade policy developments, and nuanced segmentation patterns across products, procedures, and end-user channels. By unpacking regional variations and strategic considerations, decision-makers can navigate this complex landscape with clarity and confidence.

Analysis of groundbreaking shifts reshaping aesthetic medicine propelled by cutting-edge technologies evolving consumer preferences and adaptive regulatory landscapes

The aesthetic medicine landscape is being reshaped by a cascade of transformative shifts that redefine how treatments are conceived, delivered, and experienced. Advancements in laser-based systems now offer unprecedented precision, enabling practitioners to target tissue with minimal collateral damage. Meanwhile, cryotechnology and focused ultrasound have emerged as potent modalities for non-surgical body contouring, reducing reliance on invasive procedures.

Equally significant, the integration of digital health platforms and diagnostic imaging is accelerating the transition toward personalized treatment regimens. Patient expectations have evolved accordingly; individuals increasingly demand bespoke interventions that align with their unique anatomical, genetic, and lifestyle factors. To address these demands, service providers are leveraging data analytics and AI-driven platforms to optimize treatment plans, enhance safety, and improve outcomes.

Concurrently, regulatory frameworks are adapting to ensure that innovation proceeds safely and responsibly. Authorities are tightening quality standards for device approval and post-market surveillance, while also exploring telemedicine guidelines to govern remote consultations and digital care delivery. As a result, industry participants must navigate an evolving compliance environment that balances rapid product development with rigorous safety validation.

Together, these interconnected forces illustrate a sector in the midst of profound metamorphosis, propelled by technological ingenuity, shifting patient preferences, and agile regulatory oversight.

Comprehensive assessment of the cumulative effects of United States tariffs implemented in 2025 on supply chains pricing strategies and market accessibility

The introduction of United States tariffs in 2025 has exerted a cumulative impact on the aesthetic medicine supply chain and cost structures. Initially imposed to address broader trade imbalances, these tariffs have affected both finished aesthetic devices and raw materials critical for injectable products such as dermal fillers and neurotoxins. Consequently, manufacturers have faced elevated input costs that necessitate strategic cost management across procurement and production processes.

In response, global suppliers have explored alternative sourcing strategies, including nearshoring of component manufacturing and diversification of vendor portfolios. Some have renegotiated contracts to share tariff burdens, while others have absorbed costs temporarily to maintain market competitiveness. However, these measures have varied effectiveness across different product categories, with high-complexity devices proving less amenable to rapid supply restructuring.

Moreover, regional distributors and clinical practices have adjusted pricing strategies to account for increased landed costs, often recalibrating service fees and promotional offerings. Smaller providers in particular have encountered challenges in preserving margin levels without compromising patient accessibility. At the same time, larger chains have leveraged economies of scale to buffer the financial impact, underscoring a divergence in resilience across market participants.

Collectively, these developments underscore the importance of proactive supply chain management and adaptive pricing frameworks. As the industry moves forward, stakeholders must continue to monitor policy shifts closely and build greater flexibility into their sourcing and cost models.

Insights into multifaceted market segmentation in aesthetic medicine revealing trends across product types procedures technologies demographics categories and applications

A deep dive into market segmentation offers critical insights into consumer behavior and growth drivers within aesthetic medicine. Analysis based on product type reveals that sophisticated aesthetic devices have captured significant investment due to continuous innovation in energy-based technologies, while creams and gels maintain steady demand as consumers seek noninvasive skin-care regimens. Simultaneously, implants and injections & fillers continue to evolve through formulation enhancements that improve biocompatibility and longevity.

When examined through the lens of procedure type, non-invasive treatments outpace surgical interventions by virtue of reduced recovery times and lower perceived risk. Still, surgical procedures retain a loyal segment of the market, driven by patients seeking immediate, dramatic results that only operative techniques can deliver. Cross-sectional analysis highlights how providers are integrating both approaches into tiered service offerings to accommodate diverse patient preferences.

Technological segmentation further illustrates the multiplicity of therapeutic modalities in play. Cryotechnology is gaining traction for targeted fat reduction, while laser-based systems remain the gold standard for resurfacing and pigment correction. LED-based technologies serve as adjunctive tools for photobiomodulation, and ultrasound applications are expanding into volumetric heating and collagen remodeling.

Gender-based analysis indicates that female consumers continue to drive overall market growth, yet male adoption rates are climbing rapidly as stigma surrounding cosmetic enhancement diminishes. In parallel, category segmentation differentiates generic options from prescribed formulations, each capturing unique consumer profiles based on cost sensitivity and clinician guidance.

Application-centric insights reveal that body contouring encompasses both non-surgical modalities such as cryolipolysis and HIFU as well as surgical approaches including abdominoplasty and liposuction. Facial rejuvenation trajectories underscore the popularity of botulinum toxin, dermal fillers, and thread lifts, while skin rejuvenation protocols span chemical peels, laser treatments, and microdermabrasion. Within scar treatment, emerging bioactive compounds and regenerative medicine techniques are forging new therapeutic avenues.

End-user segmentation highlights how beauty centers offer accessible entry-level services, dermatology clinics emphasize medical oversight, and medical spas combine luxury experiences with clinical expertise. Hospitals provide integrated care for complex procedures, whereas home care settings leverage direct-to-consumer distribution for topical products. Finally, distribution channels such as hospital pharmacies, online pharmacies, and retail pharmacies shape the pathways through which products reach end users, each presenting distinct regulatory and logistical considerations.

Regional analysis highlighting divergent growth trajectories and strategic opportunities across Americas Europe Middle East Africa and Asia-Pacific markets

Regional dynamics within aesthetic medicine underscore divergent growth trajectories and strategic considerations that vary by geography. In the Americas, robust investment in advanced devices and high consumer spending power have solidified the United States as a global leader. Latin American markets are propelled by an emerging middle class and strong cultural acceptance of aesthetic enhancements, creating fertile ground for noninvasive treatment adoption.

Across Europe, the Middle East & Africa, mature regulatory frameworks in major European nations foster stringent quality assurance and drive demand for premium technologies. Simultaneously, Middle Eastern markets exhibit a rising affinity for luxury medical spa experiences, supported by favorable tourism policies. African markets, while nascent, demonstrate potential through partnerships with international providers and pilot programs that introduce affordable, scalable aesthetic services.

The Asia-Pacific region stands out for its rapid digital integration and medical tourism ecosystems. Key markets such as China, Japan, and South Korea lead in technological innovation and consumer education, while emerging economies like India and Southeast Asian nations showcase accelerating clinic growth and expanding distribution networks. Cross-border patient flows further catalyze competition and incentivize service differentiation.

Ultimately, these regional insights affirm that a one-size-fits-all approach is untenable. Industry participants must tailor their strategies to local regulatory requirements, cultural preferences, and infrastructural realities to maximize market penetration and sustain long-term growth.

Insightful overview of leading companies driving innovation partnerships and competitive positioning within the aesthetic medicine landscape

Leaders within the aesthetic medicine sector are distinguished by their commitment to continuous innovation, strategic partnerships, and expansive geographic reach. Major device manufacturers have invested heavily in research and development to refine energy-based platforms and enhance user interfaces, securing a competitive edge through differentiated performance and safety profiles. Concurrently, injectables firms are diversifying pipelines with next-generation formulations that prioritize biostimulatory properties and minimized adverse events.

Collaboration between industry incumbents and emerging technology startups has accelerated the translation of novel modalities from concept to clinic. Joint ventures and licensing agreements enable large organizations to tap into disruptive advancements, while smaller innovators benefit from established distribution networks and regulatory expertise. In parallel, cross-sector partnerships-such as those between dermatology clinics and medical device companies-have fostered integrated service models that bolster patient retention and lifetime value.

Global expansion remains a core focus, with key players leveraging local partnerships and strategic acquisitions to penetrate high-growth markets. These initiatives are often accompanied by robust training programs and digital support tools to ensure consistent clinical outcomes across diverse settings. Additionally, leading companies are embracing sustainability and ethical sourcing as differentiators, responding to increasing stakeholder scrutiny around environmental impact and social responsibility.

Through these concerted efforts in innovation, collaboration, and market expansion, top-tier organizations are reinforcing their positions at the forefront of aesthetic medicine, setting benchmarks for quality and performance.

Strategic recommendations empowering industry leaders to capitalize on emerging trends optimize operations and navigate evolving regulatory environments

To capitalize on the dynamic shifts within aesthetic medicine, industry leaders should prioritize investment in next-generation technologies that enhance safety and patient comfort. Fostering collaborative relationships with technology innovators will grant early access to breakthrough modalities and streamline product development cycles. Furthermore, optimizing supply chain resilience through diversified sourcing and strategic inventory management can mitigate the impact of future trade policy changes.

Enhancing digital engagement platforms and teleconsultation services will broaden patient reach and foster deeper relationships, particularly in regions where in-person access is limited. At the same time, refining pricing models to balance value and affordability will enable practices to retain core clientele while attracting new demographics, including male consumers and emerging middle-income segments.

Proactive regulatory intelligence and compliance capabilities are essential to navigate evolving requirements across jurisdictions. Establishing dedicated governance functions will accelerate product approvals and reduce time to market. In addition, prioritizing comprehensive training and certification programs for clinical practitioners will safeguard treatment quality and reinforce brand reputation.

Ultimately, adopting a data-driven approach to patient insights and operational performance will empower decision-makers to refine service offerings, optimize resource allocation, and sustain competitive advantage in an increasingly sophisticated marketplace.

Transparent research methodology detailing data sources analytical approaches validation processes and quality assurance protocols

The research methodology underpinning this report integrates both qualitative and quantitative approaches to ensure robust and reliable insights. Primary data collection involved structured interviews with key opinion leaders, device manufacturers, clinical practitioners, and regulatory experts across major markets. These dialogues provided firsthand perspectives on technological adoption, market challenges, and strategic priorities.

Secondary research encompassed a thorough review of industry publications, regulatory filings, patent databases, and corporate disclosures. Trade association reports and academic studies were consulted to validate emerging trends and historical market developments. Data triangulation techniques were employed to cross-verify findings, mitigating the risk of bias and enhancing analytical rigor.

Quantitative analysis included statistical modeling of procedural volume trends, adoption rates of core technologies, and regional growth patterns. Projections and scenario analyses were developed through sensitivity testing of key variables such as tariff impacts and demographic shifts. All data sources underwent multi-tier validation, with discrepancies resolved through follow-up consultations.

Quality assurance protocols encompassed iterative peer reviews by subject matter experts and senior analysts. This comprehensive methodological framework ensures that the conclusions and recommendations presented are grounded in accurate, up-to-date information and reflect the nuanced realities of the aesthetic medicine market.

Conclusive synthesis of key findings implications and strategic imperatives shaping the future of aesthetic medicine

This executive summary synthesizes critical findings that illuminate the evolving landscape of aesthetic medicine. Technological breakthroughs in energy-based and injectable platforms, coupled with shifting patient expectations and adaptive regulatory frameworks, are redefining the modalities available to practitioners. At the same time, the introduction of United States tariffs in 2025 has underscored the importance of agile supply chain strategies and adaptive pricing models.

Nuanced segmentation insights reveal diverse growth drivers across product types, procedures, technologies, demographics, applications, end-user channels, and distribution pathways. Regional analyses highlight differentiated market maturity and strategic imperatives in the Americas, Europe Middle East & Africa, and Asia-Pacific. Meanwhile, leading companies continue to invest in innovation, strategic partnerships, and global expansion to maintain competitive positioning.

In conclusion, industry participants that embrace data-driven decision-making, foster collaborative alliances, and remain vigilant to regulatory shifts will be best positioned to capture emerging opportunities. By integrating the recommendations outlined herein, stakeholders can enhance operational resilience, drive sustainable growth, and deliver superior patient outcomes in a rapidly evolving market environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI-driven imaging analysis to deliver personalized filler dosing and injectables recommendations
  • 5.2. Adoption of tele-aesthetic consultations with virtual reality facial mapping to guide remote treatment planning
  • 5.3. Regulatory approval of novel muscle-selective neurotoxins targeting smaller facial muscles for micro-wrinkle refinement
  • 5.4. Popularity of combined polynucleotide and peptide cocktails to enhance skin barrier function and reduce photoaging
  • 5.5. Rising investment in 3D bioprinted facial cartilage for nasolabial fold augmentation and structural support
  • 5.6. Emergence of sustainable biotech-derived dermal fillers using plant-based hyaluronic acid alternatives
  • 5.7. Surge in demand for at-home light-based skincare devices for noninvasive skin tightening
  • 5.8. Expansion of male-targeted minimally invasive body contouring treatments using cryolipolysis and high-intensity focused ultrasound
  • 5.9. Introduction of fractional radiofrequency microneedling combined with platelet-rich plasma for acne scar correction
  • 5.10. Rapid growth of exosome-based regenerative therapies for skin rejuvenation in aesthetic clinics

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Aesthetic Medicine Market, by Product Type

  • 8.1. Introduction
  • 8.2. Aesthetic Devices
  • 8.3. Creams & Gels
  • 8.4. Implants
  • 8.5. Injections & Fillers

9. Aesthetic Medicine Market, by Procedures

  • 9.1. Introduction
  • 9.2. Non-Invasive Procedures
  • 9.3. Surgical Procedures

10. Aesthetic Medicine Market, by Technology

  • 10.1. Introduction
  • 10.2. Cryotechnology
  • 10.3. Laser-Based
  • 10.4. LED-Based
  • 10.5. Ultrasound

11. Aesthetic Medicine Market, by Gender

  • 11.1. Introduction
  • 11.2. Female
  • 11.3. Male

12. Aesthetic Medicine Market, by Category

  • 12.1. Introduction
  • 12.2. Generic
  • 12.3. Prescribed

13. Aesthetic Medicine Market, by Application

  • 13.1. Introduction
  • 13.2. Body Contouring
    • 13.2.1. Non-Surgical Body Contouring
      • 13.2.1.1. Cryolipolysis
      • 13.2.1.2. HIFU
    • 13.2.2. Surgical Body Contouring
      • 13.2.2.1. Abdominoplasty
      • 13.2.2.2. Liposuction
  • 13.3. Facial Rejuvenation
    • 13.3.1. Botulinum Toxin
    • 13.3.2. Dermal Filler
    • 13.3.3. Thread Lift
  • 13.4. Scar Treatment
  • 13.5. Skin Rejuvenation
    • 13.5.1. Chemical Peel
    • 13.5.2. Laser Treatment
    • 13.5.3. Microdermabrasion

14. Aesthetic Medicine Market, by End User

  • 14.1. Introduction
  • 14.2. Beauty Centers
  • 14.3. Dermatology Clinics
  • 14.4. Home Care Settings
  • 14.5. Hospitals
  • 14.6. Medical Spas

15. Aesthetic Medicine Market, by Distribution Channel

  • 15.1. Introduction
  • 15.2. Hospital Pharmacy
  • 15.3. Online Pharmacy
  • 15.4. Retail Pharmacy

16. Americas Aesthetic Medicine Market

  • 16.1. Introduction
  • 16.2. United States
  • 16.3. Canada
  • 16.4. Mexico
  • 16.5. Brazil
  • 16.6. Argentina

17. Europe, Middle East & Africa Aesthetic Medicine Market

  • 17.1. Introduction
  • 17.2. United Kingdom
  • 17.3. Germany
  • 17.4. France
  • 17.5. Russia
  • 17.6. Italy
  • 17.7. Spain
  • 17.8. United Arab Emirates
  • 17.9. Saudi Arabia
  • 17.10. South Africa
  • 17.11. Denmark
  • 17.12. Netherlands
  • 17.13. Qatar
  • 17.14. Finland
  • 17.15. Sweden
  • 17.16. Nigeria
  • 17.17. Egypt
  • 17.18. Turkey
  • 17.19. Israel
  • 17.20. Norway
  • 17.21. Poland
  • 17.22. Switzerland

18. Asia-Pacific Aesthetic Medicine Market

  • 18.1. Introduction
  • 18.2. China
  • 18.3. India
  • 18.4. Japan
  • 18.5. Australia
  • 18.6. South Korea
  • 18.7. Indonesia
  • 18.8. Thailand
  • 18.9. Philippines
  • 18.10. Malaysia
  • 18.11. Singapore
  • 18.12. Vietnam
  • 18.13. Taiwan

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. AbbVie Inc.
    • 19.3.2. Aerolase Corp
    • 19.3.3. Apyx Medical Corporation
    • 19.3.4. BIOTEC ITALIA SRL
    • 19.3.5. BTL Group
    • 19.3.6. Candela Corporation
    • 19.3.7. Cutera, Inc.
    • 19.3.8. Cynosure Inc.
    • 19.3.9. El.En. S.p.a.
    • 19.3.10. EndyMed
    • 19.3.11. Fotona d.o.o.
    • 19.3.12. Galderma SA
    • 19.3.13. Inmode Ltd
    • 19.3.14. Ipsen Pharma
    • 19.3.15. Jeisys Medical Co., Ltd.
    • 19.3.16. Lumenis Be Ltd.
    • 19.3.17. Lutronic Inc.
    • 19.3.18. Merz Pharma GmbH & Co.KGaA
    • 19.3.19. Quanta System S.p.A.
    • 19.3.20. Revance Therapeutics, Inc.
    • 19.3.21. Sciton, Inc.
    • 19.3.22. Sinclair Pharma Ltd.
    • 19.3.23. Venus Concept
    • 19.3.24. Bausch Health Companies Inc.
    • 19.3.25. Cutis Medical Laser Clinics Pte Ltd

20. ResearchAI

21. ResearchStatistics

22. ResearchContacts

23. ResearchArticles

24. Appendix

LIST OF FIGURES

  • FIGURE 1. AESTHETIC MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL AESTHETIC MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 24. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ASIA-PACIFIC AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 28. ASIA-PACIFIC AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. AESTHETIC MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. AESTHETIC MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 31. AESTHETIC MEDICINE MARKET: RESEARCHAI
  • FIGURE 32. AESTHETIC MEDICINE MARKET: RESEARCHSTATISTICS
  • FIGURE 33. AESTHETIC MEDICINE MARKET: RESEARCHCONTACTS
  • FIGURE 34. AESTHETIC MEDICINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. AESTHETIC MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AESTHETIC MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AESTHETIC MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY AESTHETIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY AESTHETIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CREAMS & GELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY INJECTIONS & FILLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY INJECTIONS & FILLERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CRYOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CRYOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LASER-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LASER-BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LED-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LED-BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRESCRIBED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY PRESCRIBED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HIFU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HIFU, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ABDOMINOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ABDOMINOPLASTY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LIPOSUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DERMAL FILLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DERMAL FILLER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY THREAD LIFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY THREAD LIFT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SCAR TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SCAR TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CHEMICAL PEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY CHEMICAL PEEL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LASER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY LASER TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MICRODERMABRASION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MICRODERMABRASION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BEAUTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY BEAUTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AESTHETIC MEDICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES AESTHETIC MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. CANADA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 180. CANADA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 181. CANADA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 182. CANADA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 183. CANADA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 184. CANADA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 185. CANADA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 186. CANADA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. CANADA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 199. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 201. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 202. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 203. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 206. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 207. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 208. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 209. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 210. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 211. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 212. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 213. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 214. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 215. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 217. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 218. MEXICO AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 219. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 222. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 223. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 225. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 226. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 227. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 228. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 229. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 231. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 232. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 233. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 234. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 235. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 236. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 237. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 238. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 239. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 240. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 241. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 243. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. BRAZIL AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 245. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 247. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 248. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 249. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 252. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 253. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 254. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 255. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 258. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 259. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 260. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 261. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 262. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 263. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 264. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 265. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 266. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 267. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. ARGENTINA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA AESTHETIC MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 303. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 305. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 307. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 309. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY NON-SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 315. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY SURGICAL BODY CONTOURING, 2025-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY FACIAL REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY SKIN REJUVENATION, 2025-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED KINGDOM AESTHETIC MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 325. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 328. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY PROCEDURES, 2025-2030 (USD MILLION)
  • TABLE 329. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 331. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 332. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
  • TABLE 333. GERMANY AESTHETIC MEDICINE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 334. GERMANY